Guerbet is a global specialist in contrast media and solutions for diagnostic and interventional radiology with +90 years of expertise in medical imaging.
The Company originated with Marcel Guerbet’s discovery of Lipiodol®, the first iodinated organic contrast media in 1901.
Since it was founded by André Guerbet in 1926, Guerbet has expanded significantly, thanks to innovations that have left their mark on medical imaging technologies.
Today, Guerbet provides a comprehensive range with contrast media, injection systems, medical devices digital solutions and services adapted to the needs of the medical community.
More recently, the company structured a new product range devoted to Women Healthcare.
The Group’s main products are:
- Diagnostic Imaging Products for CT Cath Lab and MRI
- Injection Systems for CT Cath Lab and MRI
- Digital solutions and Services for CT Cath Lab and MRI
- Interventional Imaging, including Cancer Solutions, Microcatheters & Women Healthcare Products Portfolio
Guerbet recently launched a strategic initiative to develop solutions utilizing AI applications to ultimately improve the diagnosis and treatment of patients toward augmented radiology.